✦ LIBER ✦

Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings

✍ Scribed by J. J. Holst; T. Vilsbøll

Book ID: 115185097
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 590 KB
Volume: 15
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2012.01628.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treating Patients With Diabetes of Long

Treating Patients With Diabetes of Long Duration: GLP-1 Receptor Agonists and Insulin in Combination

✍ Moghissi, Etie 📂 Article 📅 2014 🏛 American Osteopathic Association 🌐 English ⚖ 447 KB

Patients with long-standing type 2 diabetes mellitus (T2DM) can be clinically challenging for physicians to treat because these patients often lack sufficient β-cell function to respond to some oral glucose-lowering agents, may have profound comorbidities, and may have renal impairment that limits t

Combination of omeprazole with GLP-1 ago

Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice

✍ Patel, Vishal; Joharapurkar, Amit; Dhanesha, Nirav; Kshirsagar, Samadhan; Detroj 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 461 KB

Least Glucose Variability Is Observed wi

Least Glucose Variability Is Observed with the Combination of a GLP-1 Receptor Agonist and Basal Insulin Among Four Commonly Used Insulin Regimen in Type 2 Diabetes (VARIATION Study)

✍ Bajaj, Harpreet; Venn, Karri; Ye, Chenglin; Khandwala, Hasnain; Aslam, Nadeem; T 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 50 KB

Evidence from randomized clinical trials

Evidence from randomized clinical trials demonstrating improved glycemic control with GLP-1 receptor agonists when used with other agents vs other combination therapy strategies

✍ Freeman, Jeffrey S. 📂 Article 📅 2013 🏛 The American College of Osteopathic Family Physici 🌐 English ⚖ 365 KB

Potentiation of insulin secretion and im

Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists

✍ Nakashima, Ryutaro; Yano, Tatsuya; Ogawa, Junko; Tanaka, Naomi; Toda, Narihiro; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Insulin avoidance and treatment outcomes

Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

✍ K. Y. Thong; R. E. J. Ryder; M. L. Cull; C. Walton; on behalf of the ABCD nation 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB